# IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

> **NCT00351559** · NA · COMPLETED · sponsor: **XDx** · enrollment: 629 (actual)

## Conditions studied

- Graft Rejection
- Heart Diseases

## Interventions

- **DEVICE:** AlloMap molecular expression testing
- **PROCEDURE:** Right ventricular endomyocardial biopsy

## Key facts

- **NCT ID:** NCT00351559
- **Lead sponsor:** XDx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 629 (ACTUAL)
- **Last updated:** 2009-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351559, "IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00351559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*